Mustgrow Biologics Corp. · TSXV:MGRO
Mustgrow Biologics — Investor Presentation (October 2026)
10 slides from Mustgrow Biologics's investor presentation, October 2026
Slide 1: Providing High Growth Regenerative Agriculture Solutions
Providing High Growth Regenerative Agriculture Solutions Corporate Presentation TSXV: MGRO OTCQB: MGROF October 2026 FRA: 0C0
Slide 2: Disclaimer
Disclaimer This presentation is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities of MustGrow Biologics Corp. (“MustGrow”) nor shall there be any sale of securities in any jurisdicti
Slide 3: MustGrow is a provider of biological products & technologies derived from mustard
MustGrow is a provider of biological products & technologies that are derived from mustard to support sustainable farming The #1 thing every farmer Commercial cares about is growing a Massive Market Partnership • US$380 billion (2032 crop and protecting it from est.) global fertilizer & • Estimating
Slide 4: Sustainable Agriculture is the Future of Food Security
Sustainable Agriculture is the Future of Food Security Increased Regulation on … Commitment to Organic Large and Growing Global Demand for Synthetic Chemicals… Solutions & Growth Natural Biologics (estimated 2032) The consolidated list of banned pesticides lists 568 Bayer expects to access more than
Slide 5: Using Extracts from Mustard to Create Agriculture Products
Using Extracts from Mustard to Create Agriculture Products Mustard Seed Meal ▪ MustGro Invest (EPA Reg. No. 87862-1) ▪ Crushed seed with oil removed ▪ Bulky, inefficient ▪ Registered Biofertility Product ▪ Pre-Registered Biocontrol Product ▪ Registered in key US-states ▪ Active ingredient is AITC to
Slide 6: MustGrow's Commercial Sales Expansion is in Process
MustGrow’s Commercial Sales Expansion is in Process Commercialized Pre-registered Products & Technologies • MustGrow owned • Biocontrol in ROW • Seeking fast-track biofertility product in • US$850M* registrations in other the US countries around the world • 2.0% of acres • US$100M* • Testing in The
Slide 7: TerraSante Biofertility: U.S. Sales Strategy
TerraSanteTM Biofertility: U.S. Sales Strategy Registered in Key States Targeting High Value Crops • California, Florida, Arizona, Idaho, Oregon, Washington, • Fruit & vegetables; tree, nut & vine; root & tuber; potatoes Georgia, etc. • 5.6 million acres (187,000 acres of organic) in the US* • Organ
Slide 8: Partnering with Manufactures for Production
Partnering with Manufactures for Production Asset-Light Estimated Grower Level Revenue Opportunity MustGrow has a CURRENT ACTIONABLE viable production plan that can ramp Production Capacity (tonnes of TerraSanteTM) ~550 ~2,000-3,900 up significantly as the Potential Revenue (CAD) $20M $50-100M busin
Slide 9: Capital Structure
TSXV:MGRO Capital Structure OTCQB:MGROF FRA:0C0 Common Shares Outstanding 70,441,359 Warrants 16,862,730 Options/RSUs/DSUs 4,426,947 Convertible debentures 133,332 Fully-Diluted Shares Outstanding 91,864,368 Market Cap (CAD) $30,000,000 Mgmt. & Advisor Ownership 17% Average Volume (3 month) 45,000 P
Slide 10: Experienced Leadership Team
Experienced Leadership Team Lean executive team has the vision, energy and experience to execute Corey Giasson, MBA Colin Bletsky Todd Lahti, CFA, CPA, CA CEO & Director COO & Director CFO • 8 years with Company • 8 years with Company • 13 years with Company • 25 Years Experience • 30 Years Experien
MustGrow Biologics — Investor Presentation (October 2026) on 6ix